Cholera Vaccine Market Definition
Cholera is a bacterial disease caused by the ingestion of food or water contaminated with the bacterium Vibrio cholerae, which can lead to dehydration and even death if untreated. According to the World Health Organization (WHO) each year there are 1.3 million to 4.0 million cases of cholera, and 21 000 to 143 000 deaths worldwide due to cholera. Cholera vaccine is a sterile suspension of equal parts of Ogawa and Inaba serotypes of killed Vibrio cholerae (V. comma) in buffered sodium chloride injection and that can be injected intracutaneously (intradermally), subcutaneously or intramuscularly. In January 2020, Emergent BioSolutions Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for the approval of the company’s single-dose oral cholera vaccine, Vaxchora (Cholera Vaccine, Live, Oral).
The market study is broken down by Type (Shanchol, Dukoral, Vaxchora and Others) and major geographies with country level splits.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Cholera Vaccine market throughout the predicted period.
PaxVax, Inc. (United Sates), Valneva SE (France), Emergent BioSolutions, Inc. (United States), Astellas Pharma, Inc. (Japan), Sanofi S.A. (France), Eubiologics Co., Ltd. (South Korea), Johnson & Johnson (United States), Celldex Therapeutics, Inc. (United States), Merck & Co., Inc. (United States) and GlaxoSmithKline plc. (United Kingdom) are some of the key players that are part of study coverage.
AdvanceMarketAnalytics has segmented the market of Global Cholera Vaccine market by Type, Application and Region.
On the basis of geography, the market of Cholera Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-users, the sub-segment i.e. Hospital will boost the Cholera Vaccine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Serogroup, the sub-segment i.e. Serogroup O1 will boost the Cholera Vaccine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In October 2018, Emergent BioSolutions Inc. has announced that it has completed its acquisition of PaxVax, a company focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases.
- Increased Research and Development Activities
- Rising Government Initiatives for Development of Vaccines
- Increasing Number of Cholera Patients Worldwide
- Rise in the Hospitals and Clinics
- Growing Healthcare Infrastructure in Emerging Economies
- Growth in the Healthcare Industry Worldwide
- Huge Investments by Major Players
- Robust Increase in the Distribution Channels
- High Cost Associated with the Development of the Vaccine
- Changing Structure of the Viruses
- Stringent Government Rules and Regulations
Key Target AudienceCholera Vaccine Manufacturers, Distributors, Emerging Companies, Research Professionals and End-users
About ApproachThe research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase